Geneos Wealth Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Geneos Wealth Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14	Closed	-$2K	–	3197
2021 Q1	$2K	Buy	+14	New	+$1.9K	﹤0.01%	2972
2018 Q4	–	Sell	-13	Closed	-$1K	–	2515
2018 Q3	$1K	Hold	13	–	–	﹤0.01%	2400
2018 Q2	$1K	Sell	13 -100	-88%	-$8.61K	﹤0.01%	2247
2018 Q1	$9K	Hold	113	–	–	﹤0.01%	1702
2017 Q4	$10K	Hold	113	–	–	﹤0.01%	1654
2017 Q3	$8K	Buy	113 +13	+13%	+$982	﹤0.01%	1659
2017 Q2	$7K	Hold	100	–	–	﹤0.01%	1659
2017 Q1	$6K	Hold	100	–	–	﹤0.01%	1667
2016 Q4	$5K	Hold	100	–	–	﹤0.01%	1668
2016 Q3	$5K	Buy	+100	New	+$4.9K	﹤0.01%	1608

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geneos Wealth Management's PRAH Position: Q2 2021 in Review

Geneos Wealth Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 14 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in PRAH in Q3 2016 and held it in 10 quarters. The position peaked at $10K in Q4 2017. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

Geneos Wealth Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
Geneos Wealth Management sold 14 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $2K.
Geneos Wealth Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 10 quarters.
Geneos Wealth Management's PRA Health Sciences, Inc. position peaked at $10K in Q4 2017.
317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.